0001104659-22-035171.txt : 20220317 0001104659-22-035171.hdr.sgml : 20220317 20220317192011 ACCESSION NUMBER: 0001104659-22-035171 CONFORMED SUBMISSION TYPE: 5/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211231 FILED AS OF DATE: 20220317 DATE AS OF CHANGE: 20220317 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SILBER ALLAN C CENTRAL INDEX KEY: 0001009161 FILING VALUES: FORM TYPE: 5/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-39373 FILM NUMBER: 22750507 MAIL ADDRESS: STREET 1: C/O COUNSEL CORPORATION STREET 2: 700 - 1 TORONTO ST. CITY: TORONTO STATE: A6 ZIP: M5C 2V6 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: POINT Biopharma Global Inc. CENTRAL INDEX KEY: 0001811764 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 850800493 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4850 WEST 78TH STREET CITY: INDIANAPOLIS STATE: IN ZIP: 46268 BUSINESS PHONE: (647) 401-2182 MAIL ADDRESS: STREET 1: 4850 WEST 78TH STREET CITY: INDIANAPOLIS STATE: IN ZIP: 46268 FORMER COMPANY: FORMER CONFORMED NAME: Therapeutics Acquisition Corp. DATE OF NAME CHANGE: 20200511 5/A 1 tm229625-1_5aseq1.xml OWNERSHIP DOCUMENT X0306 5/A 2021-12-31 2022-02-14 0 0 0 0001811764 POINT Biopharma Global Inc. PNT 0001009161 SILBER ALLAN C 4850 WEST 78TH STREET INDIANAPOLIS IN 46268 1 1 1 0 Executive Chairman Common Stock 538087 I Trustee This Form 5 is being amended to remove the previously reported transaction involving the shares of Common Stock held indirectly by the Reporting Person as trustee, which was included in error, and to correct the number of shares of Common Stock held indirectly by the Reporting Person as trustee. Held in a trust for which the Reporting Person is the trustee. William L. Demers, by Power of Attorney for Allan C. Silber 2022-03-17